Skip to main content

ADVANCING CANCER TREATMENT

MOULTONBOROUGH, NHEIN: 83-2886283Website

Data sourced from IRS 990 public filings

ADVANCING CANCER TREATMENT ACTS MISSION IS TO MAKE THE WASHINGTON, DC METROPOLITAN AREA A LEADER IN ADVANCING CLINICAL TRIAL ACCRUAL, THUS ACCELERATING IMPROVED CANCER CARE AND TREATMENT.

Low-Income/Economically Disadvantaged
National
Direct Service Delivery
Research & Evaluation
Disease-Specific Services
Health
Medical Research

Annual Revenue

$43,476

Known Funders

0

Grants Received

0

Financial History

YearRevenueExpensesAssets
2024$43,476$824,363$714,351
2023$2,068,192$1,260,009$1,484,614
2022$3,010,183$3,103,502$683,975
2021$1,500,077$1,220,509$1,176,243
2020$1,600,117$1,173,683$496,629
2019$604,430$534,237$70,195

Top Funders

No funder data available yet for this nonprofit.

Key Personnel

From 2024 IRS 990 filing

O

OTIS W BRAWLEY MD

DIRECTOR

R

ROBERT L GROSSMAN

DIRECTOR

J

JEANNY B ARAGON-CHING MD

DIRECTOR

D

DONALD L TRUMP MD

DIRECTOR

A

ADAM R METWALLI MD

DIRECTOR

P

PAMELA BROWN

VICE PRESIDENT, SECRETARY

Officer
D

DAVID BROWN

PRESIDENT, TREASURER

Officer

Frequently Asked Questions

Other Nonprofits in New Hampshire

All nonprofits in New Hampshire

Unlock Full Nonprofit Data

Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.

Unlock full data & AI matching Sign up free